DPP4 and viral infectious disease: In addition, immunomodulatory effects of DPP-4 inhibitors may reduce exaggeration of the immune response in viral infections; thereby decreasing the risk of immune-mediated tissue injury as in Covid-19 (Al-Kuraishy et al. 2021e).